Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Development and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4
Burslem et al (2018) The advantages of targeted protein degradation over inhibition: an RTK case study
ClH/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8
Cu2+ and Zn2+ are linked with the neurotoxicity of -Amyloid and free radical damage
KDM4B-IN-B3 is also potent in inhibiting the growth of other cancer cell lines
Ximelagatran 18647 Development and binding mode assessmentXimelagatran (H 376 95) is an orally active thrombin inhibitor that selectively and competitively inhibits both free and clot bound thrombin. Ximelagatran is an anticoagulant agent with a rapid onset of anticoagulant effect, predictable, dose dependent pharmcokinetics and pharmacodynamics. Product information CAS Number: 192939 46 1 Molecular Weight: 473. 57 Formula: C24H35N5O5 Chemical Name: ethyl 2 {[(1R) 1 cyclohexyl 2 [(2S) 2 [({4 [(Z) N'
US$ 25.00
US$ 1116.30
US$ 5816.19